Duodopa (ABT-SLV187) is a first line therapy for advanced Parkinson's disease patients with severe motor fluctuations, when conventional oral therapy is not effective.

Type of Molecule

Small Molecule

Target

Dopamine

Region

Approved in US (Duopa), EU and Japan

Potential Indication Product Type Phase (1, 2, 3, Submitted, Approved)
Parkinson's New Indication Phase Approved Approved